Accelerate your enzyme discovery and design lifecycle

The Protein Engineering Biocatalysis Congress aims to expand the biocatalytic toolbox to establish scalable, sustainable, and cost-efficient API manufacturing

21 Aug 2022
Dora Wells
Clinical Content Editor

The Protein Engineering Biocatalysis Congress allows for industry leaders – such as Merck, Pfizer, GSK, Boehringer Ingelheim, AbbVie, and more – to unite and understand how recent developments in this field are accelerating commercial scale manufacturing processes.

Join us this October 26-27, in Philadelphia, to accelerate your enzyme discovery and design lifecycle and learn how other leaders of this field are doing the same.

Download the agenda here to find out more about our speaker faculty and the sessions taking place.

Key takeaways?

  • Reduce turnaround time by effectively implementing methods of in silico enzyme engineering
  • Identify better performing enzyme variants and accurately predict high-quality enzyme libraries
  • Increase success rates, reduce risks, and recover dead-end projects

Don’t miss out on a key industry date – secure your place here and save up to $500 if you book by Friday, September 2, 2022.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags